Plasminogen Activator Inhibitor-1 Promotes Formation of Endothelial Microparticles With Procoagulant Potential
- 29 October 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 106 (18) , 2372-2378
Abstract
Background— Endothelial dysfunction is emerging as a common denominator for diverse and highly prevalent cardiovascular diseases. Increased level of plasminogen activator inhibitor-1 (PAI-1) and procoagulant activity have been recognized as hallmarks of endothelial dysfunction. This study was aimed at investigating cellular actions of PAI-1 and a potential link between PAI-1 and procoagulant state. Methods and Results— Human umbilical vein endothelial cells treated with PAI-1 were subjected to laser confocal fluorescence microscopy, immunoprecipitation and Western blotting, and FACS analysis for isolation and identification of endothelial microparticles. PAI-1 treatment resulted in a reduced expression of uPAR, its colocalization with caveolin, and the concomitant increase of uPAR abundance in the culture medium. FACS analysis revealed that PAI-1 rapidly and dose-dependently increased the number of endothelial microparticles expressing uPAR and α V β 3 integrin. This process was attenuated by pretreatment with neutralizing anti-uPAR antibodies. PAI-1 knockout mice showed a significantly decreased number of circulating endothelial microparticles than wild-type mice; however, PAI-1–deficient animals responded to infusion of PAI-1 with a more pronounced rise in the number of microparticles. PAI-1 treatment increased the number of microparticles stained with Annexin V, evidence for the expression of anionic phospholipids. This was accompanied by the accelerated generation of thrombin. Conclusions— The data disclose a novel effect of PAI-1 to dose-dependently promote formation of endothelial microparticles with the reduced transmembrane asymmetry of phospholipids. This phenomenon may be responsible for the observed increase in in vitro thrombin generation. These findings could potentially link these hallmarks of endothelial dysfunction—elevated levels of PAI-1 and propensity toward thrombosis.Keywords
This publication has 31 references indexed in Scilit:
- Shedding of the Matrix Metalloproteinases MMP-2, MMP-9, and MT1-MMP as Membrane Vesicle-Associated Components by Endothelial CellsThe American Journal of Pathology, 2002
- Plasminogen activator inhibitor type 1 is a potential target in renal fibrogenesisKidney International, 2000
- In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulantJournal of Clinical Investigation, 1999
- The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection.Journal of Clinical Investigation, 1997
- Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis.Journal of Clinical Investigation, 1995
- Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization.Journal of Clinical Investigation, 1993
- Structurally distinct plasma membrane regions give rise to extracellular membrane vesicles in normal and transformed lymphocytesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1988
- Paradoxical Vasoconstriction Induced by Acetylcholine in Atherosclerotic Coronary ArteriesNew England Journal of Medicine, 1986
- Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery.Journal of Clinical Investigation, 1986
- Factor VII binding to tissue factor in reconstituted phospholipid vesicles: induction of cooperativity by phosphatidylserineBiochemistry, 1986